Last update 23 Sep 2025

Ac-225-RYZ-401

Overview

Basic Info

Drug Type
Therapeutic radiopharmaceuticals
Synonyms
RYZ-401
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Gastro-Enteropancreatic Neuroendocrine TumorNeuroendocrine tumor of pancreasSolid tumor
Inactive Indication-
Originator Organization-
Active Organization
Bristol Myers Squibb Co.Bristol Myers Squibb Co.Rayzebio, Inc.Rayzebio, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Ac-225-RYZ-401
NCT07165132
/ Not yet recruitingPhase 1
Phase 1 First-in-Human (FIH), Dose Escalation and Dose Expansion Study of RYZ401, a Novel Radiopharmaceutical Therapy Labeled With Actinium-225 (225Ac), in Subjects With Neuroendocrine Tumors (NETs) and Other Selected Solid Tumors Expressing Somatostatin Receptors (SSTRs).
100 Clinical Results associated with Ac-225-RYZ-401
Login to view more data
100 Translational Medicine associated with Ac-225-RYZ-401
Login to view more data
100 Patents (Medical) associated with Ac-225-RYZ-401
Login to view more data
100 Deals associated with Ac-225-RYZ-401
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gastro-Enteropancreatic Neuroendocrine TumorPhase 1-
Rayzebio, Inc.Rayzebio, Inc.
01 Oct 2025
Neuroendocrine tumor of pancreasPhase 1-
Rayzebio, Inc.Rayzebio, Inc.
01 Oct 2025
Solid tumorPhase 1-
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
01 Oct 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free